CClinicalTrials.gg
CompletedNCT06833359NDIUpdated Apr 18, 2025

Validity, Reliability of Neck Disability Index in Albanian

An observational study in Myofascial Pain Dysfunction Syndrome and Trigger Point Pain, Myofascial, sponsored by Universidad Católica San Antonio de Murcia. Completed at 1 site in Spain. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-04-18.

Sponsored by Universidad Católica San Antonio de Murcia · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
582
Ages
18 Years and older
Sex
All
01

Study summary

To translate and validate the Cervical Disability Index (NDI) into Albanian for use in the Albanian-speaking population

Read the detailed description

The cross-cultural adaptation will be carried out according to the internationally recommended methodology, following the guidelines: translation, back-translation; dissemination of questionnaires and data collection and analysis.

Psychometric properties will be assessed by administering the questionnaire to approximately 400 participants. Reliability will be estimated by assessing stability and homogeneity.

02

Conditions studied

  • Myofascial Pain Dysfunction Syndrome
  • Trigger Point Pain, Myofascial

Keywords

  • Validity
  • cross-cultural adaptation
  • Albanian Neck Disability index
  • Translation
03

In context

Myofascial Pain Syndromes

1,136 studies on the registry are indexed under Myofascial Pain Syndromes; 137 are open to participants now.

This study's enrollment of 582 is above the median of 90 across 181 observational studies indexed under Myofascial Pain Syndromes.

Browse Myofascial Pain Syndromes studies →

Lead sponsor

Universidad Católica San Antonio de Murcia is the lead sponsor of 132 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

adults with cervical pain

Inclusion criteria

  • Myofascial syndrome
  • Headache
  • muscular pain
  • articular pain
  • arthirtis

Exclusion criteria

Exclusion Criteria:

  • contraindications to manual therapy
  • severe trauma
  • tumor
  • metabolic disease
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
582 participants (actual)
Patient registry
No

Interventions

  • OtherObservation

    The Cervical Disability Index will be taught individually online through the Google questionnaire.

06

What researchers measure

Primary outcomes

  1. Albanian Neck Disability Index

    An online questionnaire used to assess the impact of neck pain on patients' activities of daily living and quality of life which consists of 10 items, each addressing a specific dimension of functionality or symptoms related to neck disorders.Each item includes five response options ranging from 0 to 5 points, where 0 indicates the absence of problems or limitations and 5 represents the maximum inability or restriction to perform the evaluated activity. The total score is calculated by adding the values of the 10 items, with a maximum of 50 points.

    Time frame: 7 days

07

Study locations

1 site
  • Jasemin Todri
    Murcia, 30107, Spain
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06833359
Lead sponsor
Universidad Católica San Antonio de Murcia
Responsible party
Jasemin Todri (Professor, Universidad Católica San Antonio de Murcia) — Principal investigator
First posted
Feb 18, 2025
Start date
Feb 16, 2025
Primary completion
Feb 25, 2025
Completion
Apr 14, 2025
Last update
Apr 18, 2025

Study contacts

Jasemin Todri
principal investigator · UCAM Universidad Catolica San Antonio de Murcia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion